Figure 1: Direct comparative pre- and postoperative evaluation of C16-AC in the blood of cardiosurgical patients (p=0.018). This group A (n=7 pts.) had clear lower preoperative ejection fraction. Highest level of C16-AC was found when patients suffered from myocardial infarction within 6 months pre op.